Showing results (2221-2230 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 12, 2020
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)Enrique Grande, Alex Teulé, Teresa Alonso-Gordoa, et al.The Oncologist|February 12, 2020
Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating MutationWei Zhang, Junping Shi, Rentao Li, et al.The Oncologist|February 12, 2020
Challenges Conveying Clinical Equipoise and Exploring Patient Treatment Preferences in an Oncology Trial Comparing Active Monitoring with Radiotherapy (ROAM/EORTC 1308)Frances C Sherratt, Stephen L Brown, Brian J Haylock, et al.The Oncologist|November 8, 2019
Diagnosis and Management of Rare Immune-Related Adverse EventsSara R Schoenfeld, Mary E Aronow, Rebecca Karp Leaf, et al.The Oncologist|March 7, 2020
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor CohortJason M Heckert, Sarit T Kipnis, Shria Kumar, et al.The Oncologist|February 22, 2020
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled StudyWei Deng, Jinsong Yang, Wenjie Ni, et al.The Oncologist|March 11, 2018
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03)Carmine Pinto, Maurizio Di Bisceglie, Francesca Di Fabio, et al.The Oncologist|December 14, 2018
BRCA1/2 Functional Loss Defines a Targetable Subset in LeiomyosarcomaNathan D Seligson, Esko A Kautto, Edward N Passen, et al.The Oncologist|August 16, 2017
Are Disagreements in Caregiver and Patient Assessment of Patient Health Associated with Increased Caregiver Burden in Caregivers of Older Adults with Cancer?Tina Hsu, Matthew Loscalzo, Rupal Ramani, et al.The Oncologist|January 26, 2019
Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort StudyJung Il Lee, Jung-Hwan Yu, Sung Gwe Anh, et al.Pageof 571